A role for calcineurin in Alzheimer's disease

Current Neuropharmacology

Volumn 9, Issue 4, 2011, Pages 685-692

  Reese, Lindsay C ^a   Taglialatela, Giulio ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Alzheimers; Amyloid beta; Calcineurin; Calcium

Indexed keywords

AMYLOID BETA PROTEIN; CALCINEURIN; TACROLIMUS; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; COGNITION; DRUG MECHANISM; HUMAN; MEMORY DISORDER; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SYNAPSE;

EID: 82955245629     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015911798376316     Document Type: Review

References (100)

1. Klee, C.B.; Krinks, M.H. Purification of cyclic 3'5'-nucletoide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to sepharose. Biochemistry, 1978, 17, 120-126.
2. Klee, C.B.; Crouch, T.H.; Krinks, M.H. Calcineurin calciumbinding and calmodulin-binding protein of the nervous system. PNAS, 1979, 76, 6270-6273.
3. Yakel, J.L. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharm. Sci., 1997, 18, 124-134.
4. Rusnak, F.; Mertz, P. Calcineurin: form and function. Physiol. Rev., 2000, 80, 1483-1521.
5. Liu, J.; Farmer, J.D.; Lane, W.S.; Friedman, J.; Weissman, I.; Schreiber, S.L. Calcineurin is a common target of cyclophilincyclosporine A and FKBP-FK506 complexes. Cell, 1991, 66, 807-815.
6. Clipstone, N.A.; Crabtree, G.R. Identification of calcineurin as a key signaling enzyme in lymphocyte-t activation. Nature, 1992, 357, 695-697.
7. Molkentin, J. D.; Lu, J.R.; Antos, C. L.; Markham, B.; Richardson, J.; Robbins, J.; Grant, S. R.; Olson, E. N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 1998, 93, 215-28.
8. Bito, H.; Deisseroth, K.; Tsien R.W. CREB phosphorylation and dephosphorylation: a Ca2(+) and stimulus duration-dependent switch for hippocampcal gene expression. Cell, 1996, 87, 1203 1214.
9. Groth, R.D.; Dunbar, R.L.; Mermelstein, P.G. Calcineurin regulation of neuronal plasticity. Biochem. Biophys. Res. Commun., 2003, 311, 1159-1171.
10. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science, 1999, 284, 339-343.
11. Asai, A.; Qiu, J.; Narita, Y.; Chi, S.; Saito, N.; Shinoura, N.; Hamada, H.; Kuchino, Y.; Kirino, T. High level calcineurin activity predisposes neuronal cells to apoptosis. J. Biol. Chem., 1999, 274, 34450-34458.
12. Rao, A.; Luo, C.; Hogan, P.G. Transcription factors of the NFAT family: regulation and function. Ann. Rev. Immun., 1997, 15, 707-747.
13. Mulkey, R.M.; Endo, S.; Shenolikar, S.; Malenka, R.C. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature, 1994, 369, 486-488.
14. Goto, S.; Yamamoto, H.; Fukunaga, K.; Iwasa, T.; Matsukado, Y.; Miyamoto, E. Dephosphorylation of microtubule-associated protein 2, tau-factor, and tubulin by calcineurin. J. Neurochem., 1985, 45, 276-283.
15. Drewes, G.; Mandelkow, E.M.; Baumann, K.; Goris, J.; Merlevede, W.; Mandelkow, E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. FEBS Lett., 1993, 336, 425-432.
16. Kim, Y.; Lee, Y.I.; Seo, M.; Kim, S.Y.; Lee, J.E.; Youn, H.D.; Kim, Y.S.; Juhnn, Y.S. Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells. J. Neurochem., 2009, 111, 344-354.
17. Li, S.; Hong, S.; Shepardson, N.E.; Walsh, D.M.; Shankar, G.M.; Selkoe, D. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron, 2009, 62, 788-801.
18. Chad, J.E.; Eckert, R. An enzymatic mechanisms for calcium current inactivation in dialysed helix neurons. J. Physiol., 1986, 378, 31-51.
19. Marrion N.V. Calcineurin regulates M channel modal gating in sympathetic neurons. Neuron, 1996, 16, 163-173.
20. Chen, T.C.; Law, B.; Kondratyuk, T.; Rossie, S. Identification of soluble-protein phosphatases that dephosphorylate voltagesensitive sodium-channels in rat brain. JBC, 1995, 270, 7750-7756.
21. 2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons. J. Neurophys., 2005, 93, 1406-1417.
22. 2+ dependent glutamate release in isolated nerve terminals. J. Neurosci., 2001, 21, 7944 7953.
23. Hilfiker, S.; Pieribone, V.A.; Czernik, A.J.; Kao, H.T.; Augustine, G.J.; Greengard, P. Synapsins as regulators of neurotransmitter release. Philos. Trans. R. Soc. Lond. B Biol. Sci., 1999, 354, 269 279.
24. Sun, T.; Wu, X.S.; Xu, J.; McNeil, B.D.; Pang, Z.P.; Wanjun, Y.; Bai, L.; Qadri, S.; Molkentin, J.D.; Yue, D.T.; Wu, L.G. The role of calcium/calmodulin-activated calcineurin in rapid and slow endocytosis at central synapses. J. Neurosci., 2010, 30, 11838-11847.
25. 2+ dependent phosphatase. Nature, 1994, 369, 235-239.
26. Tong, G.; Shepherd, D.; Jahr, C.E. Synaptic desensitization of NMDA receptors by calcineurin. Science, 1995, 5203, 1510-1512.
27. Martina, M.; Mozrzymas, J.W.; Boddeke, H.W.G.M.; Cherubini, E. The calcineurin inhibitor cyclosporine A cyclophilin A complex reduces desensitization of GABA(A)-mediated responses in acutely dissociated rat hippocampal neurons. Neurosci. Lett., 1996, 215, 95-98.
28. Lu, Y.M.; Mansuy, I.M.; Kandel, E.R.; Roder, J. Calcineurinmediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. Neuron, 2000, 26, 197-205.
29. Boddeke, H.W.G.M.; Meigel, I.; Boeijinga, P.; Arbuckle, J.; Docherty, R.J. Modulation by calcineurin of 5-HT3 receptor function in NG108-15 neuroblastoma x glioma cells. Br. J. Pharm., 1996, 118, 1836-1840.
30. Khiroug, L.; Sokolova, E.; Giniatullin, R.; Afzalov, R.; Nistri, A. Recovery from densensitization of neuronal acetylcholine receptors of rat chromaffin cells is modulated by intracellular calcium through distinct second messengers. J. Neurosci., 1998, 18, 2458-2466.
31. Bliss, T.V.P.; Collingridge, G.L. A synaptic model of memory long term potentiation in the hippocampus. Nature, 1993, 361, 31-39.
32. Bliss, T.V.P.; Lømo, T. Long-lasting potentiation of synaptic transmission in dentate area of anesthetized rabbit following stimulation of perforant path. J. Physiol. London, 1973, 232, 331-356.
33. Malinow, R. AMPA receptor trafficking and long-term potentiation. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2003, 358, 707-714.
34. Frey, U.; Krug, M.; Reymann, K.; Matthies, H. Anisomycin, an inhibitor of protein-synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res., 1988, 452, 57-65.
35. Berridge, M.J.; Bootman, M.D.; Roderick, H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol., 2003, 4, 517-529.
36. Stefan, M.I.; Edelstein, S.J.; Novère, N.L. An allosteric model of calmodulin explains differential activation of PP2B and CaMKII. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 10768-10773.
37. Hemmings, H.C.; Greengard, P.; Tung, H.Y.L.; Cohen, P. DARPP 32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature, 1984, 310, 503-505.
38. Nishi, A.; Bibb, J.A.; Matsuyama, S.; Hamada, M.; Higashi, H.; Nairn, A.C.; Greengard, P. Regulation of DARPP-32 dephosphorylation at PKA and Cdk5 sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. J. Neurochem., 2002, 81, 832-841.
39. Beattie, E.C.; Carroll, R.C.; Yu, X.; Morishita, W.; Yasuda, H.; von Zastrow, M.; Malenka, R.C. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci., 2000, 3, 1291-1300.
40. Foster, T.C. Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell, 2007, 6, 319-325.
41. Mansuy, I.M.; Mayford, M.; Jacob, B.; Kandel, E.R.; Bach, M.E. Restricted an regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell, 1998, 92, 39-49.
42. Mansuy, I.M.; Winder, D.G.; Moallem, T.M.; Osman, M.; Mayford, M.; Hawkins R.D.; Kandel, E.R. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron, 1998, 21, 257-265.
43. Zeng, H.K.; Chattarji, S.; Barbarosie, M.; Rondi-Reig, L.; Philpot, B.D.; Miyakawa, T.; Bear, M.F.; Tonegawa, S. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell, 2001, 107, 617 629.
44. Ikegami, S.; Inokuchi, K. Antisense DNA against calcineurin facilitates memory in contextual fear conditioning by lowering the threshold for hippocampal long-term potentiation. Neuroscience, 2000, 98, 637-646.
45. Malleret, G.; Haditsch, U.; Genoux, D.; Jones, M.W.; Bliss, T.V.P.; Vanhoose, A.M.; Weitlauf, C.; Kandel, E.R.; Winder, D.G.; Mansuy, I.M. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell, 2001, 104, 675-686.
46. Altman, J.; Das, D.G. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Compar. Neurol., 1965, 124, 319-335.
47. Eriksson, P.S.; Perfilieva, E.; Bjork-Eriksson, T.; Alborn, A.M.; Nordberg, C.; Peterson, D.A.; Gage, F.H. Neurogenesis in the adult human hippocampus. Nat. Med., 1998, 4, 1313-1317.
48. Reiter, R.J. Oxidative processes and anti-oxidative defense mechanisms in the aging brain. FASEB J., 1995, 9, 526-533.
49. Leslie, S.W.; Chandler, L.J.; Barr, E.M.; Farrar, R.P. Reduced calcium-uptake by rat brain mitochondria and synaptosomes in response to aging. Brain Res., 1985, 329, 177-183.
50. 2+ dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science, 1984, 226, 1089-1092.
51. Landfield, P.W.; Campbell, L.W.; Hao, S.Y.; Kerr, D.S. Agingrelated increases in voltage-sensitive, inactivating calcium currents in rat hippocampus. Implications for mechanisms of brain aging and Alzheimer's disease. Ann. N. Y. Acad. Sci. 1989, 568, 95-105.
52. 2+ release. J. Neurosci., 2006, 26, 3482-3490.
53. 2+ dysregulation with brain aging. J. Neurosci., 2001, 21, 4066-4073.
54. Jouvenceau, A.; Dutar, P. A role for the protein phosphatase 2B in altered hippocampal synaptic plasticity in the aged rat. J. Physiol. Paris, 2006, 99, 154-161.
55. Norris, C.M.; Blalock, E.M.; Chen, K.C.; Porter, N.M.; Landfield, P.W. Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture. Neuroscience, 2002, 110, 213-225.
56. Norris, C.M.; Blalock, E.M.; Chen, K.C.; Porter, N.M.; Thibault, O.; Kraner, S.D.; Landfield, P.W. Hippocampal 'zipper' slice studies reveal a necessary role for calcineurin in the increased activity of L-type Ca(2+) channels with aging. Neurobiol. Aging, 2010, 31, 328-338.
57. Norris, C.M.; Kadish, I.; Blalock, E.M.; Chen. K.C.; Thibault. V.; Porter, N.M.; Landfield, P.W.; Kraner, S.D. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J. Neurosci., 2005, 25, 4649-4658.
58. Walsh, D.M.; Selkoe, D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron, 2004, 44, 181-193.
59. Gong, Y.S.; Chang, L.; Viola, K.L.; Lacor, P.N.; Lambert, M.P.; Finch, C.E.; Krafft, G.A.; Klein, W.L. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Pro. Nat. Acad. Sci. U.S.A., 2003, 100, 10417-10422.
60. Lacor, P.N.; Buniel, M.C., Chang, L.; Fernandez, S.J.; Gong, Y.S.; Viola, K.L.; Lambert, M.P.; Velasco, P.T.; Bigio, E.H.; Finch, C.E.; Krafft, G.A.; Klein, W.L. Synaptic targeting by Alzheimer'srelated amyloid beta oligomers. J. Neurosci., 2004, 24, 10191 10200.
61. Lacor, P.N.; Buniel, M.C.; Furlow, P.W.; Clemente, A.S.; Velasco, P.T.; Wood, M.; Viola, K.L.; Klein, W.L. A beta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci., 2007, 27, 796-807.
62. Deshpande, A.; Kawai, H.; Metherate, R.; Glabe, C.G.; Busciglio, J. A role for synaptic zinc in activity-dependent A beta oligomer formation and accumulation at excitatory synapses. J. Neurosci., 2009, 29, 4004-4015.
63. Zhao, D.; Watson, J.B.; Xie, C.W. Amyloid β prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. J. Neurophysiol., 2004, 92, 2853-2858.
64. Chen, Q.S.; Wei, W.Z.; Shimahara, T.; Xie, C.W. Alzheimer amyloid b-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem., 2002, 77, 354-371.
65. Dineley, K.T.; Kayed, R.; Neugebauer, V.; Fu, Y.; Zhang, W.; Reese, L.C.; Taglialatela, G. Amyloid beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J. Neurosci. Res., 2010, 88, 2923-2932.
66. Shankar, G.M.; Bloodgood, B.L.; Townsend, M.; Walsh, D.M.; Selkoe, D.J.; Sabatini, B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci., 2007, 27, 2866-2875.
67. Arispe, N.; Rojas, R.; Pollard, H.B. Alzheimer-disease amyloid beta-protein forms calcium channels in bilayer membranes blockade by tromethamine and aluminum. PNAS, 1993, 90, 567-571.
68. De Felice, F.G.; Velasco, P.T.; Lambert, M.P.; Viola, K.; Fernandez, S.J.; Ferreira, S.T.; Klein, W.L. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptordependent mechanism that is blocked by the Alzheimer drug memantine. JBC, 2007, 282, 11590-11601.
69. Hernandez, C.M.; Kayed, R.; Zheng, H.; Sweatt, J.D.; Dineley, K.T. Loss of alpha 7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's Disease. J. Neurosci., 2010, 30, 2442-2453.
70. Renner, M.; Lacor, P.N.; Velasco, P.T.; Xu, J.A.; Contractor, A.; Klein, W.L.; Triller, A. Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron, 2010, 66, 739-754.
71. Lorenzo, A.; Yuan, M.L.; Zhang, Z.H.; Paganetti, P.A.; Sturchler Pierrat, C.; Staufenbiel, M.; Mautino, J.; Sol Vigo, F.; Sommer, B.; Yankner, B.A. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat. Neurosci., 2000, 3, 460-464.
72. Demuro, A.; Mina, E.; Kayed, R.; Milton, S.C.; Parker, I.; Glabe, C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem., 2005, 280, 17294-17300.
73. Agostinho, P.; Oliveira, C. Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides. Eur. J. Neurosci., 2003, 17, 1189-1196.
74. Reese, L.C.; Zhang, W.; Dineley, K.T.; Kayed, R.; Taglialatela G. Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Aging Cell, 2008, 7, 824-835.
75. Kuchibhotla, K.V.; Goldman, S.T.; Lattarulo, C.R.; Wu, H.Y.; Hyman, B.T.; Bacskai, B.J. A beta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron, 2008, 59, 214-225.
76. Wu, H.Y.; Hudry, E.; Hashimoto, T.; Kuchibhotla, K.; Rozkaine, A.; Fan, Z.; Spires-Jones, T.; Xie, H.; Arbel-Ornath, M.; Grosskreutz, C.L.; Bacskai, B.J.; Hyman, B.T. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J. Neurosci., 2010, 30, 2636-2649.
77. Dineley, K.T.; Hogan, D.; Zhang, W.R.; Taglialatela, G. Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol. Learn. Mem., 2007, 88, 217-224.
78. Taglialatela, G.; Hogan, D.; Zhang, W.R.; Dineley, K.T. Intermediate and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav. Brain Res., 2009, 200, 95-99.
79. Loo, D.T.; Copani, A.; Pike, C.J.; Whittemore, E.R.; Walencewicz, A.J.; Cotman, C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. PNAS, 1993, 90, 7951-7955.
80. Agostinho, P.; Lopes, J.P.; Velez, Z.; Oliveira, C.R. Overactivation of calcineurin induced by amyloid-beta and prion proteins. Neurochem. Intl., 2008, 52, 1226-1233.
81. Abdul, H.M.; Sama, M.A.; Furman, J.L.; Mathis, D.M.; Beckett, T.L.; Weidner, A.M.; Patel, E.S.; Baig, I.; Murphy, M.P.; LeVine, H.; Kraner, S.D.; Norris, C.M. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J. Neurosci., 2009, 29, 12957-12969.
82. Grundke-Iqbal, I.; Iqbal, K.; Tung, Y.C.; Quinlan, M.; Wisniewski, H.M.; Binder, L.I. Abnormal phosphorylation of the microtubuleassociated protein-tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A., 1986, 83, 4913-4917.
83. Goedert, M.; Crowther, R.A.; Garner, C.C. Molecular characterization of microtubule-associated proteins-tau and MAP2. Trends Neurosci., 1991, 14, 193-199.
84. Lindwall, G.; Cole, R.D. Phosphorylation affects the ability of tau-protein to promote microtubule assembly. J. Biol. Chem., 1984, 259, 5301-5305.
85. Drechsel, D.N.; Hyman, A.A.; Cobb, M.H.; Kirschner, M.W. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell., 1992, 3, 1141 1154.
86. Iqbal, K.; Alonso, A.D.C.; Chen, S.; Chohan, M.O.; El-Akkad, E.; Gong, C.X.; Khatoon, S.; Li, B.; Liu, F.; Rahman, A.; Tanimukai, H.; Grundke-Iqbal, I. Tau pathology in Alzheimer disease and other tauopathies. Biochim et Biophys. Acta Mol. Basis Disease, 2005, 1739, 198-210.
87. Gong, C.X.; Singh, T.J.; Grundekeiqbal, I.; Igbal, K. Alzheimersdisease abnormally phosphorylated-tau is dephosphorylated by protein phosphatase-2B (calcineurin). J. Neurochem., 1994, 62, 803 806.
88. Billingsley, M.L.; Ellis, C.; Kincaid, R.L.; Martin, J.; Schmidt, M.L.; Lee, V.M.Y.; Trojanowski, J.W. Calcineurin immunoreactivity in Alzheimers-disease. Exp. Neurol., 1994, 126, 178-184.
89. Brion, J.P.; Couck, A.M.; Conreur, J.L. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimers-disease. Neurodegeneration, 1995, 4, 13-21.
90. Ermak, G.; Morgan, T.E.; Davies K.J. Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. J. Biol. Chem., 2001, 276, 787-794.
91. Cook, C.N.; Hejna, M.J.; Magnuson, D.J.; Lee, J.M. Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease. J. Alzheimers Dis., 2005, 8, 63-73.
92. Yu, D.Y.; Tong, L.; Song, G.H.; Lin, W.L.; Zhang, L.Q.; Bai, W.; Gong, H.; Yin, Y.X.; Wei, Q. Tau binds both subunits of calcineurin, and binding is impaired by calmodulin. Biochim. et Biophys. Acta Mol. Cell Res., 2008, 1783, 2255-2261.
93. Hanger, D.P.; Hughes, K.; Woodgett, J.R.; Brion, J.P.; Anderton, B.H. Glycogen-synthase kinase-3 induces Alzheimers disease-like phosphorylation of tau generation of paired helical filament epitopes and neuronal localization of the kinase. Neurosci. Lett., 1992, 147, 58-62.
94. Tackenberg, C.; Brandt, R. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J. Neurosci., 2009, 29, 14439-14450.
95. Lian, Q.Y.; Ladner, C.J.; Magnuson, D.; Lee, J.M. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex. Exp. Neurol., 2001, 167, 158-165.
96. Rahman, A.; Grundke-Iqbal, I.; Igbal, K. PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau. J. Neural. Transm., 2006, 113, 219-230.
97. Liu, F.; Grundke-Iqbal, I.; Iqbal, K.; Oda, Y.; Tomizawa, K.; Gong, C.X. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J. Biol. Chem., 2005, 280, 37755-37762.
98. Celsi, F.; Svedberg, M.; Unger, C.; Cotman, C.W.; Carri, M.T.; Ottersen, O.P.; Nordberg, A.; Torp, R. Beta amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol. Dis., 2007, 26, 342-352.
99. Yamamoto-Sasaki, M.; Ozawa, H.; Saito, T.; Rosler, M.; Riederer, P. Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res., 1999, 824, 300-303.
100. Reisberg, B.; Doody, R.; Stoffler, A.; Schmitt, F.; Ferris, S.; Mobius, H.J. Memantine in moderate to severe AD. NEJM, 2003, 348, 1333-1341.